Efficacy of N-163 beta-glucan in beneficially improving biomarkers of relevance to muscle function in patients with muscular dystrophies in a pilot clinical study.

Kadalraja RaghavanThanasekar SivakumarKoji IchiyamaNaoki YamamotoMangaleswaran BalamuruganVidyasagar Devaprasad DedeepiyaRajappa SenthilkumarSenthilkumar PreethySamuel Jk Abraham

Published in: Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology (2023)

This study has proven the safety of Neu REFIX beta-glucan food supplement and its efficacy in improving both plasma biomarkers and functional parameters of muscle in a short duration of 2 months. Further validation by evaluation of muscle function for a longer duration is recommended to confirm the efficacy of Neu-REFIX food supplement as a potential adjuvant DMT in muscular dystrophies.

Keyphrases

skeletal muscle
human health
early stage
resistance training
risk assessment
clinical trial
randomized controlled trial
climate change